Alkem Labs Received USFDA Approval For Itraconazole Capsules


Alkem Labs, a multinational pharma company, on Thursday received the U.S FDA approval for Itraconazole capsules. The capsules are used to treat fungal infections.

Itraconazole capsules are used to treat fungal infections in the lungs that can spread throughout the body. They are also used to treat fungal infections of the fingernails and toenails, etc.

The stock of the company on NSE during Thursday’s trading session was trading at Rs 1,886 per share higher by Rs 19 per share or 1.07% at 0933 hours. The stock has delivered 36% in a period of one year and has outperformed the BE Mid cap and BSE Healthcare indices over the same time span.

Alkem Laboratories Limited is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.

or Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔

Share on Google Plus Share on Pinterest

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments: